您的位置: 首页 > 农业专利 > 详情页

Targeted therapeutics based on engineered proteins that bind EGFR
专利权人:
发明人:
Ray Camphausen,Brent Morse,Stuart Emanuel,David Fabrizio
申请号:
US13956952
公开号:
US09234028B2
申请日:
2013.08.01
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The present invention relates to single domain proteins that bind to epidermal growth factor receptor (EGFR). The invention also relates to single domain proteins for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充